Abstract
: FDA approves Victoza (liraglutide) injection for pediatric patients with type 2 diabetes. Victoza creates the same effect as GLP-1 receptor protein and is the first non-insulin drug approved since metformin in 2000.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have